دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Prioritising oral health in cancer care
doi : 10.1016/S1470-2045(24)00724-1
Volume 26, Issue 1, January 2025, Page 1
Full-dose SBRT for the primary tumour in stage III NSCLC: a promising and safe way to selective dose escalation?
Hodgkin lymphoma therapy: minimising clinical and biological harms
Evidence for a reduction in number of cycles of immune checkpoint inhibitors
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye
Risk-prediction models and clinical challenges in the ROCkeTS study
Risk-prediction models and clinical challenges in the ROCketS study
Risk-prediction models and clinical challenges in the ROCkeTS study – Authors' reply
Non-inferiority trials: tyranny or good governance? – Authors' reply
FNAB samples with the STRAT4 assay for breast cancer diagnosis – Authors' reply
Correction to Lancet Oncol 2024; published online Dec 12. https://doi.org/10.1016/S1470-2045(24)00719-8
Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus
Africa renews commitment to an accelerated plan to end cervical cancer by 2030
Pesticide exposure and increased risk of breast cancer for women in rural Brazil
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial
Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
Integrating cancer into crisis: a global vision for action from WHO and partners
